PV belongs to the BCR::ABL1–negative MPNs and is characterized by activating mutations in JAK2 (97% exon 14; 3% exon 12) leading to the proliferation of malignant hematopoietic stem and progenitor cells [3, 4]. This evidence concerns the gene JAK2 and acquired polycythemia vera.